Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 265

1.

Hospitalization Risk During Chemotherapy for Advanced Cancer: Development and Validation of Risk Stratification Models Using Real-World Data.

Brooks GA, Uno H, Aiello Bowles EJ, Menter AR, O'Keeffe-Rosetti M, Tosteson ANA, Ritzwoller DP, Schrag D.

JCO Clin Cancer Inform. 2019 Apr;3:1-10. doi: 10.1200/CCI.18.00147.

2.

Patterns of Opioid Use in the 12 Months Following Geriatric Fragility Fractures: A Population-Based Cohort Study.

Torchia MT, Munson J, Tosteson TD, Tosteson ANA, Wang Q, McDonough CM, Morgan TS, Bynum JPW, Bell JE.

J Am Med Dir Assoc. 2019 Mar;20(3):298-304. doi: 10.1016/j.jamda.2018.09.024.

PMID:
30824217
3.

Association of Digital Breast Tomosynthesis vs Digital Mammography With Cancer Detection and Recall Rates by Age and Breast Density.

Conant EF, Barlow WE, Herschorn SD, Weaver DL, Beaber EF, Tosteson ANA, Haas JS, Lowry KP, Stout NK, Trentham-Dietz A, diFlorio-Alexander RM, Li CI, Schnall MD, Onega T, Sprague BL; Population-based Research Optimizing Screening Through Personalized Regimen (PROSPR) Consortium.

JAMA Oncol. 2019 Feb 28. doi: 10.1001/jamaoncol.2018.7078. [Epub ahead of print]

PMID:
30816931
4.

Digital Breast Tomosynthesis: Radiologist Learning Curve.

Miglioretti DL, Abraham L, Lee CI, Buist DSM, Herschorn SD, Sprague BL, Henderson LM, Tosteson ANA, Kerlikowske K; Breast Cancer Surveillance Consortium.

Radiology. 2019 Apr;291(1):34-42. doi: 10.1148/radiol.2019182305. Epub 2019 Feb 26.

PMID:
30806595
5.

Hospitalization and Survival of Medicare Patients Treated With Carboplatin Plus Paclitaxel or Pemetrexed for Metastatic, Nonsquamous, Non-Small Cell Lung Cancer.

Brooks GA, Austin AM, Uno H, Dragnev KH, Tosteson ANA, Schrag D.

JAMA Netw Open. 2018 Oct 5;1(6):e183023. doi: 10.1001/jamanetworkopen.2018.3023.

6.

Trends in Clinical Breast Density Assessment From the Breast Cancer Surveillance Consortium.

Sprague BL, Kerlikowske K, Bowles EJA, Rauscher GH, Lee CI, Tosteson ANA, Miglioretti DL.

J Natl Cancer Inst. 2019 Jan 8. doi: 10.1093/jnci/djy210. [Epub ahead of print]

PMID:
30624682
7.

Comparison of treatment of early-stage breast cancer among Nurses' Health Study participants and other Medicare beneficiaries.

Austin AM, Kapadia NS, Brooks GA, Onega TL, Eliassen AH, Tamimi RM, Holmes M, Wang Q, Grodstein F, Tosteson ANA.

Breast Cancer Res Treat. 2019 Apr;174(3):759-767. doi: 10.1007/s10549-018-05098-4. Epub 2019 Jan 3.

PMID:
30607634
8.

Adapting the Breast Cancer Surgery Decision Quality Instrument for Lower Socioeconomic Status: Improving Readability, Acceptability, and Relevance.

Durand MA, Song J, Yen RW, Sepucha K, Politi MC, Dhage S, Rosenkranz K, Margenthaler J, Tosteson ANA, Crayton E, Jackson S, Bradley A, O'Malley AJ, Volk RJ, Ozanne E, Percac-Lima S, Acosta J, Mir N, Scalia P, Ward A, Elwyn G.

MDM Policy Pract. 2018 Nov 25;3(2):2381468318811839. doi: 10.1177/2381468318811839. eCollection 2018 Jul-Dec.

9.

Multilevel Predictors of Continued Adherence to Breast Cancer Screening Among Women Ages 50-74 Years in a Screening Population.

Beaber EF, Sprague BL, Tosteson ANA, Haas JS, Onega T, Schapira MM, McCarthy AM, Li CI, Herschorn SD, Lehman CD, Wernli KJ, Barlow WE.

J Womens Health (Larchmt). 2018 Nov 27. doi: 10.1089/jwh.2018.6997. [Epub ahead of print]

PMID:
30481098
10.

Recommendations for the conduct of economic evaluations in osteoporosis: outcomes of an experts' consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the US branch of the International Osteoporosis Foundation.

Hiligsmann M, Reginster JY, Tosteson ANA, Bukata SV, Saag KG, Gold DT, Halbout P, Jiwa F, Lewiecki EM, Pinto D, Adachi JD, Al-Daghri N, Bruyère O, Chandran M, Cooper C, Harvey NC, Einhorn TA, Kanis JA, Kendler DL, Messina OD, Rizzoli R, Si L, Silverman S.

Osteoporos Int. 2019 Jan;30(1):45-57. doi: 10.1007/s00198-018-4744-x. Epub 2018 Oct 31.

11.

The Effect of Digital Breast Tomosynthesis Adoption on Facility-Level Breast Cancer Screening Volume.

Lee CI, Zhu W, Onega TL, Germino J, O'Meara ES, Lehman CD, Henderson LM, Haas JS, Kerlikowske K, Sprague BL, Rauscher GH, Tosteson ANA, Alford-Teaster J, Wernli KJ, Miglioretti DL.

AJR Am J Roentgenol. 2018 Nov;211(5):957-963. doi: 10.2214/AJR.17.19350. Epub 2018 Sep 20.

PMID:
30235000
12.

Impact of prescription drugs on second fragility fractures among US Medicare patients.

Munson JC, Bynum JPW, Bell JE, McDonough C, Wang Q, Tosteson T, Tosteson ANA.

Osteoporos Int. 2018 Dec;29(12):2771-2779. doi: 10.1007/s00198-018-4697-0. Epub 2018 Sep 19.

PMID:
30232537
13.

Deficits in preference-based health-related quality of life after complications associated with tibial fracture.

Gitajn IL, Titus AJ, Tosteson AN, Sprague S, Jeray K, Petrisor B, Swiontkowski M, Bhandari M, Slobogean G.

Bone Joint J. 2018 Sep;100-B(9):1227-1233. doi: 10.1302/0301-620X.100B9.BJJ-2017-1488.R1.

PMID:
30168778
14.

Medicare Utilization and Spending Among Nurses Compared with the General United States Population.

Kapadia NS, Austin AM, Carmichael DQ, Wang Q, Erekson ED, Feskanich D, Grodstein F, Tosteson ANA, Bynum JPW.

J Womens Health (Larchmt). 2018 Aug 17. doi: 10.1089/jwh.2017.6802. [Epub ahead of print]

PMID:
30118370
15.

Multi-level Influences on Breast Cancer Screening in Primary Care.

Onega T, Tosteson TD, Weiss J, Haas JS, Goodrich M, DiFlorio R, Brackett C, Clark C, Harris K, Tosteson ANA.

J Gen Intern Med. 2018 Oct;33(10):1729-1737. doi: 10.1007/s11606-018-4560-1. Epub 2018 Aug 3.

PMID:
30076569
16.

How Do Women View Risk-Based Mammography Screening? A Qualitative Study.

He X, Schifferdecker KE, Ozanne EM, Tosteson ANA, Woloshin S, Schwartz LM.

J Gen Intern Med. 2018 Nov;33(11):1905-1912. doi: 10.1007/s11606-018-4601-9. Epub 2018 Jul 31.

PMID:
30066118
17.

The effect of mammography screening regimen on incidence-based breast cancer mortality.

Yaffe MJ, Mittmann N, Alagoz O, Trentham-Dietz A, Tosteson AN, Stout NK.

J Med Screen. 2018 Dec;25(4):197-204. doi: 10.1177/0969141318780152. Epub 2018 Jul 26.

PMID:
30049249
18.

Malpractice Concerns, Defensive Medicine, and the Histopathology Diagnosis of Melanocytic Skin Lesions.

Titus LJ, Reisch LM, Tosteson ANA, Nelson HD, Frederick PD, Carney PA, Barnhill RL, Elder DE, Weinstock MA, Piepkorn MW, Elmore JG.

Am J Clin Pathol. 2018 Aug 30;150(4):338-345. doi: 10.1093/ajcp/aqy057.

PMID:
30007278
19.

Long-Term Results of Surgery Compared With Nonoperative Treatment for Lumbar Degenerative Spondylolisthesis in the Spine Patient Outcomes Research Trial (SPORT).

Abdu WA, Sacks OA, Tosteson ANA, Zhao W, Tosteson TD, Morgan TS, Pearson A, Weinstein JN, Lurie JD.

Spine (Phila Pa 1976). 2018 Dec 1;43(23):1619-1630. doi: 10.1097/BRS.0000000000002682.

PMID:
29652786
20.

Medical Care Costs Were Similar Across the Low-dose Computed Tomography and Chest X-Ray Arms of the National Lung Screening Trial Despite Different Rates of Significant Incidental Findings.

Gareen IF, Black WC, Tosteson TD, Wang Q, Sicks JD, Tosteson ANA.

Med Care. 2018 May;56(5):403-409. doi: 10.1097/MLR.0000000000000900.

21.

Timely follow-up of positive cancer screening results: A systematic review and recommendations from the PROSPR Consortium.

Doubeni CA, Gabler NB, Wheeler CM, McCarthy AM, Castle PE, Halm EA, Schnall MD, Skinner CS, Tosteson ANA, Weaver DL, Vachani A, Mehta SJ, Rendle KA, Fedewa SA, Corley DA, Armstrong K.

CA Cancer J Clin. 2018 May;68(3):199-216. doi: 10.3322/caac.21452. Epub 2018 Mar 30.

22.

Pathologist characteristics associated with accuracy and reproducibility of melanocytic skin lesion interpretation.

Elder DE, Piepkorn MW, Barnhill RL, Longton GM, Nelson HD, Knezevich SR, Pepe MS, Carney PA, Titus LJ, Onega T, Tosteson ANA, Weinstock MA, Elmore JG.

J Am Acad Dermatol. 2018 Jul;79(1):52-59.e5. doi: 10.1016/j.jaad.2018.02.070. Epub 2018 Mar 7.

PMID:
29524584
23.

Preoperative breast MRI and mortality in older women with breast cancer.

Onega T, Zhu W, Weiss JE, Goodrich M, Tosteson ANA, DeMartini W, Virnig BA, Henderson LM, Buist DSM, Wernli KJ, Kerlikowske K, Hubbard RA.

Breast Cancer Res Treat. 2018 Jul;170(1):149-157. doi: 10.1007/s10549-018-4732-z. Epub 2018 Mar 7.

PMID:
29516372
24.

Cost-effectiveness of mammography from a publicly funded health care system perspective.

Mittmann N, Stout NK, Tosteson ANA, Trentham-Dietz A, Alagoz O, Yaffe MJ.

CMAJ Open. 2018 Feb 8;6(1):E77-E86. doi: 10.9778/cmajo.20170106.

25.

What matters most: protocol for a randomized controlled trial of breast cancer surgery encounter decision aids across socioeconomic strata.

Durand MA, Yen RW, O'Malley AJ, Politi MC, Dhage S, Rosenkranz K, Weichman K, Margenthaler J, Tosteson ANA, Crayton E, Jackson S, Bradley A, Volk RJ, Sepucha K, Ozanne E, Percac-Lima S, Song J, Acosta J, Mir N, Elwyn G.

BMC Public Health. 2018 Feb 13;18(1):241. doi: 10.1186/s12889-018-5109-2.

26.

Breast Biopsy Intensity and Findings Following Breast Cancer Screening in Women With and Without a Personal History of Breast Cancer.

Buist DSM, Abraham L, Lee CI, Lee JM, Lehman C, O'Meara ES, Stout NK, Henderson LM, Hill D, Wernli KJ, Haas JS, Tosteson ANA, Kerlikowske K, Onega T; Breast Cancer Surveillance Consortium.

JAMA Intern Med. 2018 Apr 1;178(4):458-468. doi: 10.1001/jamainternmed.2017.8549.

27.

Communication Practices of Mammography Facilities and Timely Follow-up of a Screening Mammogram with a BI-RADS 0 Assessment.

Schapira MM, Barlow WE, Conant EF, Sprague BL, Tosteson ANA, Haas JS, Onega T, Beaber EF, Goodrich M, McCarthy AM, Herschorn SD, Skinner CS, Harrington TO, Geller B.

Acad Radiol. 2018 Sep;25(9):1118-1127. doi: 10.1016/j.acra.2017.12.028. Epub 2018 Feb 9.

28.

Underutilization of Supplemental Magnetic Resonance Imaging Screening Among Patients at High Breast Cancer Risk.

Miles R, Wan F, Onega TL, Lenderink-Carpenter A, O'Meara ES, Zhu W, Henderson LM, Haas JS, Hill DA, Tosteson ANA, Wernli KJ, Alford-Teaster J, Lee JM, Lehman CD, Lee CI.

J Womens Health (Larchmt). 2018 Jun;27(6):748-754. doi: 10.1089/jwh.2017.6623. Epub 2018 Jan 17.

PMID:
29341851
29.

Leveraging Linkage of Cohort Studies With Administrative Claims Data to Identify Individuals With Cancer.

Bronson MR, Kapadia NS, Austin AM, Wang Q, Feskanich D, Bynum JPW, Grodstein F, Tosteson ANA.

Med Care. 2018 Dec;56(12):e83-e89. doi: 10.1097/MLR.0000000000000875.

PMID:
29334524
30.

Quality of life after hip, vertebral, and distal forearm fragility fractures measured using the EQ-5D-3L, EQ-VAS, and time-trade-off: results from the ICUROS.

Svedbom A, Borgström F, Hernlund E, Ström O, Alekna V, Bianchi ML, Clark P, Curiel MD, Dimai HP, Jürisson M, Uusküla A, Lember M, Kallikorm R, Lesnyak O, McCloskey E, Ershova O, Sanders KM, Silverman S, Tamulaitiene M, Thomas T, Tosteson ANA, Jönsson B, Kanis JA.

Qual Life Res. 2018 Mar;27(3):707-716. doi: 10.1007/s11136-017-1748-5. Epub 2017 Dec 12.

PMID:
29235059
31.

Quality of life for up to 18 months after low-energy hip, vertebral, and distal forearm fractures-results from the ICUROS.

Svedbom A, Borgstöm F, Hernlund E, Ström O, Alekna V, Bianchi ML, Clark P, Curiel MD, Dimai HP, Jürisson M, Kallikorm R, Lember M, Lesnyak O, McCloskey E, Sanders KM, Silverman S, Solodovnikov A, Tamulaitiene M, Thomas T, Toroptsova N, Uusküla A, Tosteson ANA, Jönsson B, Kanis JA.

Osteoporos Int. 2018 Mar;29(3):557-566. doi: 10.1007/s00198-017-4317-4. Epub 2017 Dec 11.

PMID:
29230511
32.

Utilization of breast cancer screening with magnetic resonance imaging in community practice.

Hill DA, Haas JS, Wellman R, Hubbard RA, Lee CI, Alford-Teaster J, Wernli KJ, Henderson LM, Stout NK, Tosteson ANA, Kerlikowske K, Onega T.

J Gen Intern Med. 2018 Mar;33(3):275-283. doi: 10.1007/s11606-017-4224-6. Epub 2017 Dec 6.

33.

Comparative effectiveness of incorporating a hypothetical DCIS prognostic marker into breast cancer screening.

Trentham-Dietz A, Ergun MA, Alagoz O, Stout NK, Gangnon RE, Hampton JM, Dittus K, James TA, Vacek PM, Herschorn SD, Burnside ES, Tosteson ANA, Weaver DL, Sprague BL.

Breast Cancer Res Treat. 2018 Feb;168(1):229-239. doi: 10.1007/s10549-017-4582-0. Epub 2017 Nov 28.

34.

Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study.

Rutter CM, Kim JJ, Meester RGS, Sprague BL, Burger EA, Zauber AG, Ergun MA, Campos NG, Doubeni CA, Trentham-Dietz A, Sy S, Alagoz O, Stout N, Lansdorp-Vogelaar I, Corley DA, Tosteson ANA.

Cancer Epidemiol Biomarkers Prev. 2018 Feb;27(2):158-164. doi: 10.1158/1055-9965.EPI-17-0378. Epub 2017 Nov 17.

35.

Relationship between preoperative breast MRI and surgical treatment of non-metastatic breast cancer.

Onega T, Weiss JE, Goodrich ME, Zhu W, DeMartini WB, Kerlikowske K, Ozanne E, Tosteson ANA, Henderson LM, Buist DSM, Wernli KJ, Herschorn SD, Hotaling E, O'Donoghue C, Hubbard R.

J Surg Oncol. 2017 Dec;116(8):1008-1015. doi: 10.1002/jso.24796. Epub 2017 Nov 11.

36.

Population-Based Analysis of Histologically Confirmed Melanocytic Proliferations Using Natural Language Processing.

Lott JP, Boudreau DM, Barnhill RL, Weinstock MA, Knopp E, Piepkorn MW, Elder DE, Knezevich SR, Baer A, Tosteson ANA, Elmore JG.

JAMA Dermatol. 2018 Jan 1;154(1):24-29. doi: 10.1001/jamadermatol.2017.4060.

37.

Second opinion strategies in breast pathology: a decision analysis addressing over-treatment, under-treatment, and care costs.

Tosteson ANA, Yang Q, Nelson HD, Longton G, Soneji SS, Pepe M, Geller B, Carney PA, Onega T, Allison KH, Elmore JG, Weaver DL.

Breast Cancer Res Treat. 2018 Jan;167(1):195-203. doi: 10.1007/s10549-017-4432-0. Epub 2017 Sep 6.

38.

Pathologists' Use of Second Opinions in Interpretation of Melanocytic Cutaneous Lesions: Policies, Practices, and Perceptions.

Geller BM, Frederick PD, Knezevich SR, Lott JP, Nelson HD, Titus LJ, Carney PA, Tosteson ANA, Onega TL, Barnhill RL, Weinstock MA, Elder DE, Piepkorn MW, Elmore JG.

Dermatol Surg. 2018 Feb;44(2):177-185. doi: 10.1097/DSS.0000000000001256.

39.

Understanding the value of minimally invasive procedures for the treatment of lumbar spinal stenosis: the case of interspinous spacer devices.

Tapp SJ, Martin BI, Tosteson TD, Lurie JD, Weinstein MC, Deyo RA, Mirza SK, Tosteson ANA.

Spine J. 2018 Apr;18(4):584-592. doi: 10.1016/j.spinee.2017.08.246. Epub 2017 Aug 25.

PMID:
28847740
40.

Pathologists' diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study.

Elmore JG, Barnhill RL, Elder DE, Longton GM, Pepe MS, Reisch LM, Carney PA, Titus LJ, Nelson HD, Onega T, Tosteson ANA, Weinstock MA, Knezevich SR, Piepkorn MW.

BMJ. 2017 Jun 28;357:j2813. doi: 10.1136/bmj.j2813. Erratum in: BMJ. 2017 Aug 8;358:j3798.

41.

The diagnostic challenge of low-grade ductal carcinoma in situ.

Onega T, Weaver DL, Frederick PD, Allison KH, Tosteson ANA, Carney PA, Geller BM, Longton GM, Nelson HD, Oster NV, Pepe MS, Elmore JG.

Eur J Cancer. 2017 Jul;80:39-47. doi: 10.1016/j.ejca.2017.04.013. Epub 2017 May 20.

42.

Characteristics associated with requests by pathologists for second opinions on breast biopsies.

Geller BM, Nelson HD, Weaver DL, Frederick PD, Allison KH, Onega T, Carney PA, Tosteson ANA, Elmore JG.

J Clin Pathol. 2017 Nov;70(11):947-953. doi: 10.1136/jclinpath-2016-204231. Epub 2017 May 2.

43.

A Randomized Study Comparing Digital Imaging to Traditional Glass Slide Microscopy for Breast Biopsy and Cancer Diagnosis.

Elmore JG, Longton GM, Pepe MS, Carney PA, Nelson HD, Allison KH, Geller BM, Onega T, Tosteson AN, Mercan E, Shapiro LG, Brunyé TT, Morgan TR, Weaver DL.

J Pathol Inform. 2017 Mar 10;8:12. doi: 10.4103/2153-3539.201920. eCollection 2017.

44.

Diffusion of digital breast tomosynthesis among women in primary care: associations with insurance type.

Clark CR, Tosteson TD, Tosteson ANA, Onega T, Weiss JE, Harris KA, Haas JS.

Cancer Med. 2017 May;6(5):1102-1107. doi: 10.1002/cam4.1036. Epub 2017 Apr 4.

45.

Temporal trends in healthcare utilization following primary melanoma diagnosis among Medicare beneficiaries.

Lott JP, Wang Q, Titus LJ, Onega T, Nelson HD, Weinstock MA, Elmore JG, Tosteson ANA.

Br J Dermatol. 2017 Sep;177(3):845-853. doi: 10.1111/bjd.15530. Epub 2017 Jul 9.

PMID:
28369774
46.

Falling Down on the Job: Evaluation and Treatment of Fall Risk Among Older Adults With Upper Extremity Fragility Fractures.

McDonough CM, Colla CH, Carmichael D, Tosteson ANA, Tosteson TD, Bell JE, Cantu RV, Lurie JD, Bynum JPW.

Phys Ther. 2017 Mar 1;97(3):280-289. doi: 10.1093/ptj/pzx009.

47.

Where Is the Geriatrician?-Reply.

Bynum J, Munson J, Tosteson AN.

JAMA Intern Med. 2017 Mar 1;177(3):442-443. doi: 10.1001/jamainternmed.2016.8856. No abstract available.

PMID:
28264119
48.

National Performance Benchmarks for Modern Diagnostic Digital Mammography: Update from the Breast Cancer Surveillance Consortium.

Sprague BL, Arao RF, Miglioretti DL, Henderson LM, Buist DS, Onega T, Rauscher GH, Lee JM, Tosteson AN, Kerlikowske K, Lehman CD; Breast Cancer Surveillance Consortium.

Radiology. 2017 Apr;283(1):59-69. doi: 10.1148/radiol.2017161519. Epub 2017 Feb 28.

49.

Change in Breast Cancer Screening Intervals Since the 2009 USPSTF Guideline.

Wernli KJ, Arao RF, Hubbard RA, Sprague BL, Alford-Teaster J, Haas JS, Henderson L, Hill D, Lee CI, Tosteson ANA, Onega T.

J Womens Health (Larchmt). 2017 Aug;26(8):820-827. doi: 10.1089/jwh.2016.6076. Epub 2017 Feb 8.

50.

Alignment of breast cancer screening guidelines, accountability metrics, and practice patterns.

Onega T, Haas JS, Bitton A, Brackett C, Weiss J, Goodrich M, Harris K, Pyle S, Tosteson AN.

Am J Manag Care. 2017 Jan;23(1):35-40.

Supplemental Content

Loading ...
Support Center